[1] 喻文, 罗红敏. 基于凝血及肝肾功能指标建立的人工智能系统可协助判断百草枯中毒患者预后[J]. 中华危重病急救医学, 2017, 29(11):1051.
[2] 黄杨,孙纪元,尹文,等.221例急性百草枯中毒患者临床病死率相关数据分析[J].临床急诊杂志,2017,18(1):1-4.
DOI:10.13201/j.issn.1009-5918.2017.01.001.
[3] 陆欢,刘奇,兰超.肝损伤指标对急性百草枯中毒患者预后的评估价值[J].河南医学研究,2020,29(5):778-781. DOI:10.3969/j.issn.1004-437X.2020.05.004.
[4] 毕红英,付建宇,唐艳,等.集成血液净化治疗百草枯中毒肝衰竭患者的临床体会[J].中国中西医结合急救杂志,2017,24(6):660-662.
DOI:10.3969/j.issn.1008-9691. 2017.06.024.
[5] Ismail AF, Abidin M, Mansur S, et al.
Hemodialysis membrane for blood purification process// Ismail AF. Membrane
separation principles and applications[M]. Amsterdam: Elsevier, 2019: 283-314.
[6] Chen JJ, Huang JR, Yang Q, et al. Plasma
exchange-centered artificial liver support system in hepatitis B virus-related
acute-on-chronic liver failure: a nationwide prospective multicenter study in
China [J]. Hepatobiliary Pancreat Dis Int, 2016, 15(3):275-281. DOI:
10.1016/s1499-3872(16)60084-x.
[7] 董静,刘龙梅,陈照林,等.富马酸替诺福韦二吡呋酯联合双重血浆分子吸附系统序贯血浆置换治疗慢加急性乙型肝炎肝衰竭患者疗效分析[J].实用肝脏病杂志,2020,23(5):687-690.
DOI:10.3969/j.issn.1672-5069.2020.05.021.
[8] 兰小勤,纪雅丽,陈金军,等.基于MELD评分分层分析人工肝治疗对平台期肝衰竭患者短期预后的影响[J].临床肝胆病杂志,2020,36(9):2005-2009. DOI:10.3969/j.issn.1001- 5256.2020.09.019.
[9] Wu G, Wu D, Lo J, et al. A bioartificial
liver support system integrated with a DLM/GelMA-based bioengineered whole
liver for prevention of hepatic encephalopathy via enhanced ammonia reduction
[J]. Biomater Sci, 2020, 8(10): 2814-2824. DOI: 10.1039/c9bm01879d.
[10] Li P, Liang X, Xu S, et al. A
non-bioartificial liver support system combined with transplantation in
HBV-related acute-on-chronic liver failure [J]. Sci Rep, 2021, 11(1): 2975.
DOI: 10.1038/s41598-021-82719-x.
[11] Damania A, Kumar A, Sarin SK, et al.
Optimized performance of the integrated hepatic cell-loaded cryogel-based
bioreactor with intermittent perfusion of acute liver failure plasma [J]. J
Biomed Mater Res B Appl Biomater, 2018, 106(1): 259-269. DOI:
10.1002/jbm.b.33851.
[12] 刘蓉芝,胡庆,唐勇.CVVH联合HP对蜂蛰伤致多器官功能障碍综合征患者心肌酶和肝肾功能水平的影响[J].中南医学科学杂志,2020,48(1):93-96. DOI:
10.15972/j.cnki. 43-1509/r. 2020.01.024.
[13] 李宁,黎代强,谢碧占.双重血浆分子吸附系统治疗重型肝病的临床疗效[J].贵州医药,2018,42(9):1066-1068. DOI:10.3969/j.issn.1000-744X.2018.09.014.
[14] 焦月琴,赵云峰,王丽.DPMAS模式人工肝治疗早期乙型肝炎相关慢加急性肝功能衰竭的效果[J].中国实用医刊,2021,48(9):54-57.
DOI:10.3760/cma.j.cn115689- 20201202-05995.
[15] 朱立娜,黄初军,赵秋燕,等.组合型人工肝对肝功能衰竭患者血清Th1/Th2型细胞因子的影响[J].临床消化病杂志,2020,32(1):41-45. DOI:10.3870/lcxh.j.issn.1005- 541X.2020.01.010.
[16] 张晓坤,张国芹,顾春娟.双重血浆吸附人工肝治疗肝衰竭患者的护理措施分析[J/CD].实用临床护理学电子杂志,2020,5(26):41.
|